Biden Administration’s Limit on Drug Industry Middlemen Backfires, Pharmacists Say ...Middle East

KHN - News
Biden Administration’s Limit on Drug Industry Middlemen Backfires, Pharmacists Say
The Biden administration’s first major step toward imposing limits on the pharmacy benefit managers who act as the drug industry’s price negotiators is backfiring, pharmacists say. Instead, it’s adding to the woes of the independent drugstores it was partly designed to help. The so-called PBMs have long clawed back a fee from pharmacies weeks or months after they dispense a drug. A new rule, which governs Medicare’s drug program, is set to take effect Jan. 1 and requires PBMs to take most of their “performance fees” at the time prescriptions are filled. The clawbacks have ballooned from about $9 million in 2010 to $12.6 billion in 2021, according to the Medicare Payment Advi

Hence then, the article about biden administration s limit on drug industry middlemen backfires pharmacists say was published today ( ) and is available on KHN ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Biden Administration’s Limit on Drug Industry Middlemen Backfires, Pharmacists Say )

Apple Storegoogle play

Last updated :

Also on site :